glp-1 kidney outcomes news Receptor Agonist Use in Transplant Recipients in: Kidney Volume 17 Issue 8 (2025) Healthcare utilization, mortality, and cardiovascular
Description
FOR WHATS THE MEDICARE GLP-1 BRIDGE PROGRAM SOURCE: Centers for Medicare and Medicaid Services
Poulsen S
[DOI] [PMC free article] [PubMed] [Google Scholar] 104.Niazi S, Gnesin F, Thein AS, et al
Pharmacy availability at the time of approval can affect which medication is dispensed
Nutrition ACCPoCDS, Lifestyle Working G "Food is medicine" strategies for nutrition security and cardiometabolic health equity: JACC state-of-the-art review
One example is orforglipron , an oral GLP-1 for the treatment of type 2 diabetes and obesity
